CID 3011902

2'-b-c-methylsangivamycin

Structural Information

Molecular Formula
C13H17N5O5
SMILES
C[C@]1([C@@H]([C@H](O[C@H]1N2C=C(C3=C(N=CN=C32)N)C(=O)N)CO)O)O
InChI
InChI=1S/C13H17N5O5/c1-13(22)8(20)6(3-19)23-12(13)18-2-5(10(15)21)7-9(14)16-4-17-11(7)18/h2,4,6,8,12,19-20,22H,3H2,1H3,(H2,15,21)(H2,14,16,17)/t6-,8-,12-,13-/m1/s1
InChIKey
JWXUVPMFIQHRJE-CZTVAOSCSA-N
Compound name
4-amino-7-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

37
Patents

323.12296 Da
Monoisotopic Mass

-2.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 324.13024 170.2
[M+Na]+ 346.11218 179.7
[M-H]- 322.11568 172.2
[M+NH4]+ 341.15678 183.1
[M+K]+ 362.08612 177.1
[M+H-H2O]+ 306.12022 163.9
[M+HCOO]- 368.12116 186.3
[M+CH3COO]- 382.13681 206.5
[M+Na-2H]- 344.09763 170.7
[M]+ 323.12241 170.3
[M]- 323.12351 170.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe